A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
about
Solution structure and backbone dynamics of long-[Arg(3)]insulin-like growth factor-IAltered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II moleculeThe insulin-like growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysisOpposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts.Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?Insulin-like growth factors I and II.Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate.BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains.A mutant of human insulin-like growth factor II (IGF II) with the processing sites of proinsulin. Expression and binding studies of processed IGF II.The biological role of truncated insulin-like growth factor-1 and the tripeptide GPE in the central nervous system.Binding affinities of insulin-like growth factor-I (IGF-I) fusion proteins to IGF binding protein 1 and IGF-I receptor are not correlated with mitogenic activity.Insulin-like growth factor-II is a substrate for dipeptidylpeptidase I (cathepsin C). Biological properties of the product.Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions.Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological propertiesAlanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding.The Insulin-like Growth Factor (IGF) Binding Site of Bovine Insulin-like Growth Factor Binding Protein-2 (bIGFBP-2) Probed by Iodination
P2860
Q27622000-DF9BCE5B-D9C5-472E-A2C8-3D42BEEEA667Q28324041-B43DB79D-700B-46A7-8174-4C8280EA25F7Q28619274-451961B2-7D8A-4EB4-B0D5-C9F09E97DBE1Q33833669-E3B3F3FF-6BE1-4339-88DE-A1EC91EFA815Q33890792-942BAB7E-0867-431C-960F-3085A567511EQ34221300-060FD3B5-0061-4E21-B8DC-F73415F79EBFQ34367377-9D61A4DA-6CB4-426F-B6DF-75F1AF950C69Q38300759-AC5C88C5-40C3-4518-A9EC-A9956E415728Q38323666-49D17A8D-32C4-429F-AC9B-3BA4C1B7F8A9Q40768897-4E796586-C7A5-4500-A37C-D5593242B1B4Q41075374-CCD9E779-D2E0-481F-9C6F-0BB7A3125958Q41428991-0BB811BD-ED2A-4A6C-8830-EE27EFF29CABQ42811185-B74C68DD-BE4F-4274-8E0F-B252840F5E25Q42825828-CA80C414-C4AA-4FA9-80DA-07A6C151EB7BQ42826197-7BE0D73C-C426-4128-A10D-91A7E3BB6242Q47792080-78B5F348-0714-4342-A4D2-C1C6E1B263E3Q58024207-D3A6A23D-24B8-4AB3-B048-9BB0C9FC0AEA
P2860
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
@en
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
@nl
type
label
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
@en
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
@nl
prefLabel
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
@en
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
@nl
P2093
P2860
P356
P1433
P1476
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.
@en
P2093
Ballard FJ
Francis GL
McNamara PJ
Wallace JC
P2860
P304
P356
10.1042/BJ2590665
P407
P577
1989-05-01T00:00:00Z